Business ❯Pharmaceuticals ❯Drug Development

Weight Loss Drugs

Eli Lilly MariTide Market Demand GLP-1 Treatments GLP-1 Drugs Novo Nordisk AbbVie Licensing Amycretin

Roche and Zealand Partner in $5.3 Billion Deal for Obesity Drug Development

AbbVie Enters Obesity Drug Market with $2.2 Billion Licensing Deal

Merck Secures $2 Billion Deal for Experimental Oral Weight Loss Drug from Hansoh Pharma